Mar 31, 2022

Entrada Therapeutics Q1 2022 Earnings Report

EPS
-$0.69
Previous year: -$6.67
-89.7%
Cash and Equivalents
$84.6M
Previous year: $146M
-42.1%
Free Cash Flow
-$21.6M
Previous year: -$9.24M
+133.5%
Total Assets
$317M

Entrada Therapeutics

Entrada Therapeutics